Hantavirus Outbreak in 2026
The word hantavirus returned to global headlines in the first week of May 2026 with a speed and severity that few public health watchers anticipated. A cluster of severe respiratory illnesses aboard the Dutch-flagged cruise ship MV Hondius — reported to the World Health Organization on 2 May 2026 — triggered a coordinated international emergency response spanning at least five continents. By 6 May 2026, authorities had confirmed the outbreak involved the Andes strain of hantavirus (Andes virus, ANDV), an exceptionally dangerous variant notable for being the only known hantavirus capable of human-to-human transmission. With 3 deaths confirmed or suspected, 5 confirmed cases, 3 suspected cases, and 1 critically ill patient in intensive care in South Africa, the outbreak sent emergency health officials from the Netherlands, United Kingdom, Germany, Cape Verde, Spain, South Africa, Switzerland, and Singapore into coordinated action within days.
What separates the 2026 hantavirus outbreak from previous isolated incidents is the uniquely complex international dimension: the MV Hondius carried 147–149 passengers and crew from 23 nationalities, meaning potential exposures were distributed across dozens of countries, across multiple continents, before the outbreak was even formally identified. The WHO’s Disease Outbreak Notification (DON599) confirmed that the index case — a Dutch national — is believed to have contracted the Andes virus while birdwatching near a landfill in Ushuaia, Argentina, before boarding the ship on 1 April 2026, potentially after a four-month road trip across Chile, Uruguay, and Argentina. Against the backdrop of a disease that carries a case fatality rate of 35–50% for the Andes strain, and for which no approved antiviral treatment or licensed vaccine exists, the global alarm is not without solid scientific foundation.
Interesting Key Facts About the 2026 Hantavirus Outbreak
2026 HANTAVIRUS OUTBREAK — SNAPSHOT
══════════════════════════════════════════════════════════════
Ship MV Hondius (Dutch-flagged, Oceanwide Expeditions)
Total Persons on Board 149 (from 23 nationalities)
Total Cases ████████ 8 (5 confirmed + 3 suspected)
Deaths ███ 3 (1 confirmed hantavirus; 2 under investigation)
Critically Ill █ 1 (ICU, South Africa)
Mild/Symptomatic ███ 3
Strain Confirmed Andes virus (ANDV) — only H2H-transmissible strain
Andes Virus CFR ████████████████████████████ 35–50%
WHO Global Risk Level LOW (as of 4 May 2026)
No approved treatment ✗ No antiviral. ✗ No vaccine.
══════════════════════════════════════════════════════════════
| Fact | Detail |
|---|---|
| Outbreak Vessel | MV Hondius — Dutch-flagged expedition cruise ship operated by Oceanwide Expeditions |
| Departure Port & Date | Ushuaia, Argentina, 1 April 2026 |
| Intended Destination | Canary Islands (Spain) via South Atlantic islands |
| Persons on Board | 147–149 passengers and crew from 23 nationalities |
| First Death on Board | 11 April 2026 — index case died aboard; body removed in Saint Helena on 24 April |
| Hantavirus Strain Confirmed | Andes virus (ANDV) — confirmed by South Africa’s NICD; the only hantavirus with documented human-to-human transmission |
| Leading Exposure Hypothesis | Index case (Dutch national) exposed during birdwatching tour at a landfill in Ushuaia, Argentina |
| Index Case Travel History | 4-month road trip through Chile, Uruguay, and Argentina (Nov 27, 2025 – April 1, 2026) |
| Total Cases (as of 6–7 May 2026) | 8 (5 confirmed + 3 suspected) |
| Deaths | 3 (1 confirmed hantavirus-positive; 2 deaths under investigation) |
| Critically Ill | 1 patient — ICU, private medical facility, Johannesburg, South Africa |
| Swiss Case (May 6) | Patient diagnosed at University Hospital Zurich after disembarking; Andes strain confirmed |
| EU/EEA Nationalities on Board | Belgium, France, Germany, Greece, Ireland, Netherlands, Poland, Portugal, Spain — 9 EU/EEA states |
| Philippines Crew on Board | 38 Filipino crew members — none reported ill as of 7 May 2026 |
| Tenerife Docking Refusal | Spain’s Canary Islands President Fernando Clavijo refused the ship permission to dock on 6 May 2026 |
| Cape Verde Response | Ship anchored off Praia, Cape Verde, for 3 days; isolation area created; medical supplies deployed |
| WHO Global Risk Assessment | LOW — assessed as of 4 May 2026 by WHO Director-General Dr. Tedros Adhanom Ghebreyesus |
| Andes Virus Case Fatality Rate | 35–50% (UK Health Security Agency, CSIRO; WHO) |
| Approved Treatment | None — no licensed antiviral, no approved vaccine exists for hantavirus |
| Lab Confirmation Body | National Institute for Communicable Diseases (NICD), South Africa — PCR-confirmed |
Source: WHO DON599 (4 May 2026), ECDC Threat Assessment Brief (6 May 2026), Africa CDC (4 May 2026), Wikipedia MV Hondius hantavirus outbreak (6 May 2026), CNN (7 May 2026), TIME (7 May 2026)
The 2026 hantavirus outbreak aboard the MV Hondius stands as the most internationally complex hantavirus event ever recorded, by virtue of the sheer geographic spread of potentially exposed individuals across 23 nationalities and multiple continents. The facts table makes clear that the defining feature of this outbreak is the confirmed strain: Andes virus (ANDV) is a uniquely alarming pathogen not because hantavirus outbreaks are common — they are not — but because it is the only hantavirus in the world with documented human-to-human transmission capacity, a property that every other known hantavirus strain lacks entirely. The confirmation of an additional case in Switzerland after the patient had disembarked and returned home is the single most significant epidemiological detail in the table, because it confirms that the exposure chain extended beyond the ship’s immediate environment before isolation measures could contain it.
The WHO’s “low global risk” assessment is grounded in the well-established epidemiology of Andes virus: even in previous ANDV outbreaks in Argentina and Chile, human-to-human transmission was limited to close contacts — primarily household members and intimate partners — and did not produce the exponential spread characteristic of easily airborne pathogens. The death of the index case’s wife, who tested PCR-positive for the Andes strain, is consistent with this known transmission pattern of close-contact spread rather than broader community transmission. Still, the 35–50% Andes virus case fatality rate, the absence of any approved antiviral treatment, and the fact that early symptoms are indistinguishable from influenza make rapid clinical identification the sole meaningful intervention available to clinicians managing this outbreak.
2026 MV Hondius Hantavirus Outbreak: Case Timeline & Deaths in 2026
MV HONDIUS HANTAVIRUS OUTBREAK — CHRONOLOGICAL TIMELINE
═══════════════════════════════════════════════════════════════
27 Nov 2025 Index case begins 4-month Argentina/Chile/Uruguay road trip
01 Apr 2026 MV Hondius departs Ushuaia, Argentina (147-149 aboard)
06 Apr 2026 Estimated earliest symptom onset (WHO illness onset range: 6–28 Apr)
11 Apr 2026 DEATH #1: Index case (Dutch male) dies aboard; hantavirus not yet confirmed
13-15 Apr Ship visits Tristan da Cunha
24 Apr 2026 Body of Case 1 removed at Saint Helena; wife (Case 2) disembarks with symptoms
25 Apr 2026 Case 2 deteriorates mid-flight to Johannesburg
26 Apr 2026 DEATH #2: Case 2 (Dutch female, 69) dies at Johannesburg hospital; PCR+ confirmed
27 Apr 2026 Case 3 (British male) medically evacuated from Ascension → Johannesburg ICU
02 May 2026 DEATH #3: German female passenger dies on board MV Hondius
02 May 2026 UK IHR Focal Point notifies WHO; EWRS alert issued by Netherlands
03 May 2026 PCR confirms hantavirus in Case 3 (South Africa NICD); ship docks off Praia, Cape Verde
04 May 2026 WHO DON599 issued: 7 cases (2 confirmed, 5 suspected); 3 deaths; 1 critically ill
06 May 2026 ECDC brief: 8th case confirmed — Swiss national treated in Zurich after disembarking
06 May 2026 Andes virus confirmed by NICD; Canary Islands refuses docking; 3 evacuated to Netherlands
07 May 2026 MV Hondius en route to Canary Islands; Singapore isolates 2 returned passengers
═══════════════════════════════════════════════════════════════
| Date | Event | Significance |
|---|---|---|
| 27 Nov 2025 | Index case begins road trip: Chile → Uruguay → Argentina | 4-month potential rodent exposure window |
| 01 Apr 2026 | MV Hondius departs Ushuaia, Argentina | Incubation begins; no symptoms at departure (Argentine authorities) |
| 6–28 Apr 2026 | Illness onset range for all 7 cases (WHO) | Incubation period: typically ~2 weeks for hantavirus |
| 11 Apr 2026 | First death — Dutch male (index case) | First death; body removed Saint Helena 24 April |
| 24 Apr 2026 | Wife (Case 2) disembarks at Saint Helena with GI symptoms | Human-to-human transmission suspected; rapid deterioration on flight |
| 26 Apr 2026 | Second death — Dutch female, 69, at Johannesburg hospital | PCR-confirmed Andes virus (confirmed 4 May) |
| 27 Apr 2026 | Case 3 (British male) evacuated to Johannesburg ICU | Second confirmed PCR-positive; condition improving as of 7 May |
| 02 May 2026 | Third death — German female, dies aboard ship | Hantavirus under investigation; pneumonia presentation |
| 02 May 2026 | WHO notified by UK IHR Focal Point; ECDC EWRS alert | International public health emergency response initiated |
| 03 May 2026 | Lab confirmation at NICD, South Africa; ship docks off Praia | First PCR confirmation; Cape Verde creates isolation zone |
| 06 May 2026 | 8th case — Swiss national, Zurich hospital | Confirms geographic spread beyond ship before isolation |
| 06 May 2026 | Andes strain confirmed; 3 patients evacuated to Netherlands | Critical determination: human-to-human strain involved |
| 07 May 2026 | Ship heads to Canary Islands; Singapore isolates 2 returned passengers | International containment response actively ongoing |
Source: WHO DON599 (4 May 2026), Wikipedia MV Hondius hantavirus outbreak (6 May 2026), ECDC TAB (6 May 2026), CNN (7 May 2026), Africa CDC (4 May 2026)
The outbreak timeline reveals several clinically and epidemiologically critical patterns that help contextualize the scale and severity of what occurred aboard the MV Hondius. Most striking is the 22-day gap between the index case’s death on 11 April and the formal WHO notification on 2 May — a window that reflects both the inherent difficulty of diagnosing hantavirus from shipboard symptoms alone, and the logistical reality of a vessel traveling through some of the most remote waters in the southern hemisphere, far from laboratory confirmation capabilities. By the time NICD in South Africa achieved PCR confirmation on 3 May, the ship had already traveled thousands of nautical miles, passed through multiple island port calls, and discharged at least one passenger — the Swiss case — who had already returned home to Europe.
The human-to-human transmission trajectory within the cluster is deeply consistent with what is known about Andes virus epidemiology from previous outbreaks in Patagonia: the Dutch couple (Cases 1 and 2) were husband and wife in close prolonged contact, and the wife developed symptoms only after sustained exposure to the symptomatic index case. The British Case 3, who became the second PCR-confirmed case, was a passenger in an enclosed environment with relatively limited space — again consistent with ANDV’s documented requirement for close and prolonged contact rather than casual transmission. The confirmation of a Swiss passenger case after disembarkation elevated the outbreak’s international dimension from complex to unprecedented, and directly triggered the contact tracing operations that were still actively ongoing in South Africa, the Netherlands, Singapore, and Switzerland as of 7 May 2026.
2026 Hantavirus Cases by Country & International Response Statistics
COUNTRIES INVOLVED IN THE 2026 MV HONDIUS OUTBREAK RESPONSE
═══════════════════════════════════════════════════════════════
Netherlands ████████████████████ FLAG state; coordination lead; 2 deaths (Dutch couple)
South Africa ████████████████████ Medical evacuation hub; NICD lab confirmation; ICU care
Switzerland ████████████████ 8th case confirmed (Zurich); self-isolating spouse
UK ████████████ Case 3 (British ICU patient); IHR Focal Point alert
Germany ████████ 1 death (German female); 1 asymptomatic evacuated
Cape Verde ████████ Ship anchored off Praia 3–6 May; denied docking
Spain ████████ Canary Islands refused docking; final destination
Argentina ████████ Origin of infection; national investigation ongoing
Singapore ████ 2 returned passengers isolated in government facility
Philippines ████ 38 crew; none ill; in contact with authorities
═══════════════════════════════════════════════════════════════
| Country | Role / Cases | Action Taken |
|---|---|---|
| Netherlands | 2 deaths (Dutch couple); flag state of MV Hondius; 41-yr-old Dutch crew evacuated | Netherlands coordinates as flag state; Dutch MFA blog updates; KLM airline informed passengers on flight shared with Case 2 |
| South Africa | Medical evacuation destination; 1 ICU patient (British); laboratory confirmation | NICD PCR confirmed Andes virus; contact tracing initiated; receiving ICU patients |
| United Kingdom | IHR Focal Point — first to notify WHO on 2 May; 1 British ICU patient (Case 3) | UK IHR notification triggered WHO DON599; UKHSA issued clinical guidance for Andes virus |
| Germany | 1 death (German female, died on board 2 May); 1 asymptomatic German evacuated | German evacuee to be tested at Düsseldorf hospital |
| Switzerland | 8th confirmed case — Swiss male, University Hospital Zurich | Swiss Federal Office of Public Health announced case; wife self-isolating; Andes strain confirmed |
| Cape Verde | Transit stop country | Denied ship docking; isolation zone created; deployed medical support to ship anchored offshore |
| Spain (Canary Islands) | Final destination (Tenerife) | Regional president Fernando Clavijo refused permission to dock on 6 May citing public safety |
| Argentina | Likely origin of index case’s infection | National health ministry + Malbrán Institute investigating; rodent trapping along travel route; contact tracing |
| Singapore | Returned passengers | Isolated 2 residents who had been aboard MV Hondius in a government facility |
| Philippines | 38 Filipino crew members on board | None ill as of 7 May; Philippines DOH in close coordination with international authorities |
| EU/EEA Coordination | 9 EU/EEA member state nationals on board | ECDC Threat Assessment Brief issued 6 May; EWRS activated; common case definition and protocol being developed |
| WHO | Global coordination, risk assessment | DON599 issued 4 May; Global risk assessed as LOW; supporting case isolation, medical evacuation, and lab investigation |
Source: ECDC TAB (6 May 2026), TIME (7 May 2026), Africa CDC (4 May 2026), CNN (7 May 2026), Wikipedia MV Hondius (6 May 2026)
The international response to the 2026 hantavirus cluster is, by any measure, one of the most geographically distributed public health coordination efforts triggered by a single outbreak cluster in recent years. The fact that nine EU/EEA member states had nationals aboard a Dutch-flagged vessel that originated in Argentina, stopped in Antarctica, South Georgia, Tristan da Cunha, Saint Helena, Ascension Island, and Cape Verde before heading to the Canary Islands means that epidemiological contact tracing extends across six continents. The ECDC’s immediate activation of the EU’s Early Warning and Response System (EWRS), the WHO’s same-day DON issuance, and the near-simultaneous response from Africa CDC, UKHSA, South Africa’s NICD, and health ministries across Asia reflect how seriously the Andes virus strain designation was taken by global health authorities.
Argentina’s domestic investigation is particularly significant from a public health standpoint: the country’s health ministry published a detailed map of the index case’s movements, confirmed the birdwatching landfill hypothesis, and initiated rodent capture and testing along the identified travel route. This matters because the Andes virus reservoir is Argentina’s long-tailed pygmy rice rat (Oligoryzomys longicaudatus) — a small rodent common in Patagonia and the Andean foothills — and the index case’s four-month travel across precisely those high-risk ecological zones is consistent with exposure risk. Singapore’s decision to isolate and monitor two returned passengers in a government facility — even though neither was confirmed infected — reflects the precautionary approach that the Andes strain’s human-to-human transmission capacity demands from national health authorities.
Global Hantavirus Statistics: Cases, Deaths & Fatality Rates in 2026
GLOBAL HANTAVIRUS BURDEN — REGIONAL SUMMARY (2025–2026 DATA)
═══════════════════════════════════════════════════════════════
Region Annual Cases (est.) CFR Range Disease Type
────────────────────────────────────────────────────────────────
Asia (total) ████████████████████ Thousands/yr HFRS (<1–15%)
China ████████████████████ Most HFRS cases HFRS (1–5%)
South Korea ████████████████ Thousands/yr HFRS (<5%)
Europe █████████ ~1,885 (2023) HFRS (<1–15%)
Americas ████ 229 cases (2025) HCPS (20–50%)
Andes strain ██ ~handful/yr HCPS (35–50%)
═══════════════════════════════════════════════════════════════
Global estimate: 10,000–100,000 infections per year (WHO)
| Region / Country | Annual Cases (Most Recent Data) | Deaths | Case Fatality Rate | Disease Type |
|---|---|---|---|---|
| Global (all strains) | 10,000 – 100,000+ (estimated annually) | Varies widely | <1% – 50% depending on region & strain | HFRS or HCPS |
| Americas Region (2025) | 229 confirmed cases (as of epi week 47, 2025) | 59 deaths | 25.7% | HCPS (Hantavirus Cardiopulmonary Syndrome) |
| Americas (countries, 2025) | Argentina, Brazil, Bolivia, Chile, Panama, Paraguay, USA, Uruguay — 8 countries | 59 | 25.7% | HCPS |
| Europe (2023, most recent full-year) | 1,885 cases (0.4 per 100,000) — lowest rate 2019–2023 | Not separately reported here | <1% – 15% | HFRS (Haemorrhagic Fever with Renal Syndrome) |
| France (Jan–Mar 2026) | 19 confirmed cases (monthly average; in line with national average) | — | <1% (Puumala strain) | HFRS |
| French Guiana (since 2008) | 11 cases total of Maripa hantavirus pulmonary syndrome | 6 fatal | ~54.5% | HCPS |
| East Asia (China, S. Korea) | Thousands annually (declining trend) | Thousands/yr historically | 1–15% (Hantaan: 5–15%; Seoul: <1%) | HFRS |
| USA (1993–2023 cumulative) | 890 total confirmed cases (30-year surveillance) | ~38% of HPS cases fatal | ~38% for HPS (CDC) | HCPS / non-pulmonary |
| Andes Virus (ANDV) specifically | Small numbers annually; mainly Argentina, Chile | High proportion | 35–50% | HCPS — only H2H-transmissible strain |
| 2026 MV Hondius Cluster (as of 7 May) | 8 cases (5 confirmed, 3 suspected) | 3 deaths | 37.5% (3 of 8) — still evolving | HCPS (Andes strain) |
Source: WHO DON599 (4 May 2026), WHO Hantavirus Fact Sheet (2026), ECDC Annual Epidemiological Report 2023, PAHO Epidemiological Alert Dec 2025, CDC Hantavirus Surveillance Data (updated April 2026), ANRS (2026)
The global hantavirus statistics for 2025–2026 confirm what epidemiologists have known for decades: this is a disease with two dramatically different faces depending on geography. In Asia and Europe, where Hantaan, Seoul, Puumala, and Dobrava strains circulate primarily causing Haemorrhagic Fever with Renal Syndrome (HFRS), the disease burden is measured in thousands of cases per year but fatality rates are relatively manageable — below 1% for Puumala (Europe) and 5–15% for Hantaan (East Asia). In the Americas, the picture is far darker: the 229 cases and 59 deaths reported across 8 countries in 2025 — a 25.7% case fatality rate — reflect the brutal lethality of New World hantaviruses causing Hantavirus Cardiopulmonary Syndrome (HCPS), which progresses from flu-like symptoms to respiratory failure within days. The 38% HPS mortality figure from the CDC, based on three decades of US surveillance, represents a disease that kills more than one in three patients once the respiratory phase begins.
What the 2025 global data also reveals is that hantavirus case counts in the Americas are small in absolute terms but devastatingly lethal in proportion: 229 cases sounds modest on a global scale, but one in four of those people died. The French Guiana data — 6 deaths from just 11 cases since 2008 — illustrates the same brutal efficiency of New World strains. The Europe 2023 figure of 1,885 cases at a rate of 0.4 per 100,000 represents the lowest recorded rate in a five-year window, suggesting that European hantavirus burden (driven almost entirely by the Puumala strain via bank voles in Scandinavia and Central Europe) is declining — a rare piece of good news in the otherwise sobering global picture. The 2026 MV Hondius cluster’s evolving 37.5% case fatality rate sits precisely in the range expected for the Andes strain, offering grim validation of the epidemiological projections.
Hantavirus Disease Types, Symptoms & Fatality Rates: Global Statistics 2026
HANTAVIRUS DISEASE OUTCOMES BY REGION & STRAIN (2026)
═══════════════════════════════════════════════════════════════
Syndrome Region CFR Key Strains
───────────────────────────────────────────────────────────────
HCPS Americas 20–50% Andes, Sin Nombre, Black Creek Canal
HCPS Andes-specific35–50% ███████████████████████████████
HPS USA (CDC) 38% ██████████████████████████
HFRS Asia (Hantaan)5–15% ████████
HFRS Asia (Seoul) <1% █
HFRS Europe (Puum.)<1% █
HFRS Europe (Dobr.)5–12% ████
═══════════════════════════════════════════════════════════════
Incubation: ~2 weeks average | No vaccine | No antiviral approved
| Disease / Strain | Primary Region | Case Fatality Rate | Key Symptoms | Human-to-Human Transmission |
|---|---|---|---|---|
| HCPS (General — Americas) | Americas | 20–40% | Fever, muscle aches, rapid respiratory failure, lungs fill with fluid | No (except Andes) |
| Andes Virus (ANDV) — HCPS | Argentina, Chile | 35–50% | Same as HCPS; only H2H-transmissible strain | Yes — close/prolonged contact (household, intimate) |
| Sin Nombre Virus — HPS | USA (Southwest, Four Corners) | ~38% (CDC) | Flu symptoms → severe respiratory distress, 4–10 days after onset | No |
| Hantaan Virus — HFRS | China, South Korea, Russia | 5–15% | Fever, hemorrhage, renal failure | No |
| Seoul Virus — HFRS | Global (via Rattus rattus) | <1% | Mild renal syndrome | No |
| Puumala Virus — HFRS | Northern & Central Europe | <1% | Mild nephropathia epidemica (kidney disease) | No |
| Dobrava Virus — HFRS | Balkans, Eastern Europe | 5–12% | Moderate to severe renal syndrome | No |
| General HFRS (Asia/Europe) | Asia + Europe | <1% – 15% | Kidney damage, hemorrhage | No |
| Incubation Period (general) | All regions | — | ~2 weeks average (range: 1–8 weeks per CDC) | — |
| Treatment Available | Global | — | No approved antiviral. No licensed vaccine. Supportive ICU care only | — |
Source: WHO Hantavirus Fact Sheet (2026), CDC Hantavirus Data (April 2026), ECDC Factsheet (2026), CSIRO (May 2026), Newsweek (May 2026), UKHSA guidance
The clinical picture of hantavirus disease in 2026 remains as bleak as it has been since the virus was first formally identified following the 1993 Four Corners outbreak in the American Southwest. Despite three decades of scientific effort, no licensed antiviral drug and no approved vaccine exists for hantavirus infection anywhere in the world, making early ICU admission and supportive care the sole evidence-based intervention. This absence of specific treatment is what makes the 35–50% Andes virus case fatality rate so alarming in the context of the 2026 ship outbreak — every one of those percentage points represents a patient whose life depends entirely on the quality and speed of the supportive care they receive, with no pharmaceutical backstop. The ~2 week average incubation period also means that by the time a patient develops the recognizable respiratory symptoms of HCPS, the virus has already been present for weeks — complicating contact tracing and quarantine efforts significantly.
The stark contrast between Andes virus (35–50% CFR) and Puumala virus (<1% CFR) illustrates how profoundly geography determines outcomes with hantavirus. European patients infected with Puumala are overwhelmingly likely to survive; patients infected with Andes virus in South America — or, as demonstrated in 2026, aboard a cruise ship in the South Atlantic — face survival odds that are worse than many cancers. The Sin Nombre virus’s 38% HPS fatality rate from CDC’s 30-year US surveillance is a sobering reminder that hantavirus danger is not limited to the Andes strain: the American Southwest’s deer mouse-carried Sin Nombre virus has been killing people since 1993, with 890 total confirmed US cases through 2023 and consistent year-on-year mortality. The 2026 MV Hondius outbreak is not an anomaly so much as it is a high-visibility demonstration of what hantavirus — and Andes virus in particular — has always been capable of doing.
Hantavirus Global Reservoir Hosts, Distribution & Risk Factors in 2026
HANTAVIRUS GLOBAL RODENT RESERVOIR DISTRIBUTION (2026)
═══════════════════════════════════════════════════════════════
Region Rodent Host Virus Strain
───────────────────────────────────────────────────────────────
USA (SW) ██ Deer Mouse Sin Nombre (HPS)
Argentina/Chile ██ Long-tailed pygmy rice rat Andes (HCPS/H2H)
Europe (N/C) ██ Bank Vole Puumala (HFRS, mild)
Europe (Balkans)██ Yellow-necked mouse Dobrava (HFRS)
Asia (E/SE) ██ Striped field mouse Hantaan (HFRS)
Global ██ Rattus rattus (roof rat)Seoul (mild HFRS)
═══════════════════════════════════════════════════════════════
Each hantavirus strain has ONE primary rodent host species
| Hantavirus Strain | Primary Rodent Host | Geographic Range | High-Risk Human Activities |
|---|---|---|---|
| Andes Virus (ANDV) | Long-tailed pygmy rice rat (Oligoryzomys longicaudatus) | Argentina, Chile (Andean regions, Patagonia) | Birdwatching, farming, camping, landfill visits — as in the 2026 Ushuaia case |
| Sin Nombre Virus | Deer Mouse (Peromyscus maniculatus) | USA (Southwest, Four Corners region) | Cleaning enclosed spaces, camping, clearing brush |
| Hantaan Virus | Striped field mouse (Apodemus agrarius) | China, South Korea, Russia | Agricultural work, farming |
| Seoul Virus | Roof rat / Brown rat (Rattus norvegicus / Rattus rattus) | Global (via rat distribution) | Rat-infested buildings, urban areas |
| Puumala Virus | Bank Vole (Myodes glareolus) | Northern & Central Europe (Scandinavia, Finland, Germany) | Forest activities, summer cottages |
| Dobrava Virus | Yellow-necked mouse (Apodemus flavicollis) | Balkans, Eastern Europe | Rural housing, farming |
| Maripa Virus | Rodents (tropical) | French Guiana | Forest/jungle activities |
| Climate Change Impact | Multiple hosts | Expanding ranges | Rodent population booms after warm/wet periods precede human case surges |
| Australia | None identified | No confirmed human cases | Unique globally — antibodies found in rodents, no human infections recorded |
Source: WHO Hantavirus Fact Sheet (2026), CDC Hantavirus About page, CSIRO (May 2026), ANRS (2026)
The ecology of hantavirus transmission is, at its core, a story about the intersection of human activity and rodent habitat — and in 2026, that intersection is expanding. Each hantavirus strain is tightly linked to a single primary rodent reservoir species, and the virus circulates in those populations without causing disease in the animals themselves: infected deer mice, bank voles, and long-tailed pygmy rice rats shed the virus in their urine, droppings, and saliva continuously, contaminating their environments, with humans infected by inhaling aerosolized particles from those environments. The 2026 index case’s visit to a landfill in Ushuaia — identified as the leading hypothesis by Argentine investigators — is a perfect illustration of how an encounter with a single infected rodent in a high-density excreta environment can trigger a chain of events that ends in an international health emergency. Landfills and waste sites are known concentration points for rodent populations, making them disproportionate hantavirus risk environments relative to their apparent scale.
The climate change dimension is increasingly recognized by virologists and public health researchers as a driver of future hantavirus risk. Rodent population booms, driven by warmer temperatures and increased food availability, regularly precede surges in human hantavirus cases — a pattern documented across European Puumala outbreaks, Chinese HFRS seasons, and American HPS clusters. CSIRO researchers have explicitly flagged that climate change, by altering the geographic range and abundance of reservoir rodent species, is expected to shift hantavirus risk geographically — potentially bringing strains into regions where human populations have no prior exposure, no awareness, and limited health system preparedness. Australia’s unique status as the only inhabited continent with no confirmed human hantavirus cases — despite detecting hantavirus antibodies in some Australian rodents — underscores that the epidemiology of this virus is still being actively mapped, and that the geographic boundaries of risk are not fixed.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
